Ipertensione polmonare

Slides:



Advertisements
Similar presentations
Pulmonary Hypertension
Advertisements

PH: Who Ya Gonna Call Pulm Consults
Eduardo Bossone, MD, Ph.D, FESC, FACC
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
RYAN O’GOWAN, MBA, PA-C FAPACVS FCCM Pulmonary Hypertension.
This slide set has been developed by Actelion Pharmaceuticals Ltd as an educational resource for healthcare providers and other interested parties.
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
AM Report Lauren Galpin, MD MA  “Thromboembolic obstruction of the major pulmonary arteries due to unresolved pulmonary embolism [with pulmonary.
Bosentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and post- pulmonary endarterectomy pulmonary hypertension A pre-defined subgroup.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
Pulmonary Hypertension: Management Update
CO - RELATION WITH ECG INTRA CARDIAC PRESSURES ASHOK MADRAS MEDICAL MISSION CHENNAI
Doppler Echocardiography Overestimates Pulmonary Hypertension in Patients with Scleroderma Interstitial Lung Disease Kevin M Chan 1, Elena Tishkowski 2,
Prevalence of PAH in SSc ReferenceMethodologyDiagnosisPAH prevalence Mukerjee; 2003, UK n = 722, single center Prospective RHC12%
Congestive Heart Failure Stephen Gottlieb, MD Professor of Medicine Director, Cardiomyopathy and Pulmonary Hypertension University of Maryland.
Pulmonary Hypertension and Various Treatment Options
Diastolic Dysfunction as Diagnosed and Quantified by Echocardiography LAM-1965AO (07/13) For Broker/Dealer Use Only.
Ventricular Diastolic Filling and Function
Prof. Sevda Özdoğan  Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure.
Pathology of Pulmonary Hypertension Wolter J. Mooi Department of Pathology, VUmc Amsterdam
Il paziente emodinamicamente instabile Andrea Barbieri U.O. Cardiologia Policlinico di Modena “ Il percorso diagnostico dell’embolia polmonare” Modena.
Associations of Fatigue and Patient-Reported Outcomes in Pulmonary Arterial Hypertension Lea Ann Matura, PhD, RN Assistant Professor University of Pennsylvania.
Screening, Referral and Diagnosis of Pulmonary Arterial Hypertension
Evaluation of Dyspnea.
Diastolic Dysfunction is Common in Asymptomatic HIV Patients Priscilla Y. Hsue 1,2, Husam H. Farah 1,2, Ann F. Bolger 1,2, Swapna Palav 2, Samira Ahmed.
The Hemodynamics of Restrictive & Constrictive Cardiomyopathy Jad Skaf, M.D. 11/02/2010.
VASCULAR COMPLICATIONS OF SYSTEMIC SCLEROSIS Early Diagnosis of PAH in Systemic Sclerosis: How Do We Recognize the Warning Signs? Joseph C. Shanahan, MD.
Pulmonary Hypertension: Diagnostics and Therapeutics Presented by R3 林至芃
Katie DePlatchett M.D. AM Report June 29,  Elevated Pulmonary Artery pressure  Secondary R Ventricular failure  Mean Pulm Artery Pressure of.
5/98MedSlides.com1 Pulmonary (Arterial) Hypertension
Echocardiography in ICU Michel Slama AmiensFrance LEVEL 1 basic LEVEL 2: advanced.
Guidelines for the Echocardiographic Assessment of
Cardiovascular Imaging Module II Vincent Brinkman, MD and Sharon Roble, MD Division of Cardiology The Ohio State University College of Medicine.
פרופ ' נוויל ברקמן מכון הריאה ביה " ח האוניברסיטאי הדסה עין - כרם PULMONARY HYPERTENSION AND COR PULMONALE פרופ ' נוויל ברקמן מכון הריאה ביה " ח האוניברסיטאי.
Ryan Hampton OMS IV January  Considerations Is MR severe? Is patient symptomatic? Is patient a good candidate? What is Left Ventricular function?
SPM 200 Clinical Skills Lab 1
RESPIRATORY 221 WEEK 3 PULMONARY BLOOD FLOW. Vascular System  Two Systems : Each have its own reservoir, pump and set of vessels  Pulmonary Circulation.
ADULT ECHOCARDIOGRAPHY Lesson Nine Valvular Heart Disease
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Right Ventricular Dysfunction and Remodeling in Chronic.
Effort Dependence of change in 6-Minute Walk Test in Pulmonary Hypertension was improved by Correction with the Change in Heart Rate: The Beat-Yield Pulmonology.
Mitral valve Stenosis *Read pages 1 – 9 in The Echocardiographer’s Pocket Reference; Read pages 259 – 262 and 277 – 286 in Otto; Read Pages 185 – 190.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Emerging Role of Exercise Testing and Stress.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic Value of RV Function Before and After.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for the management of patients.
순환기 내과 R3 임규성 Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary Arterial Hypertension J Am Coll Cardiol.
Brain Natriuretic Peptide is a Prognostic Parameter in Chronic Lung Disease Hanno H. Leuchte, Rainer A. Baumgartner, Michal El Nounou, Michael Vogeser,
Cath. Data. Dilated Cardiomyopathy.
Pulmonary hypertension
Pulmonal hypertensjon
Echocardiographic Findings in Canine HW Disease
ADULT ECHOCARDIOGRAPHY Lesson Seven The Mitral Valve
Patrick SK. Liu Shiu Cheong
Guideline for approaching the differential diagnosis of pulmonary hypertension. CHD, congenital heart disease; CO, cardiac output; CT, contrast-enhanced.
Shilpa Johri, MD, MBBS, FCCP Pulmonary Associates of Richmond
ADULT ECHOCARDIOGRAPHY Lesson Six The Pulmonic Valve
ADULT ECHOCARDIOGRAPHY Lesson Eight The Tricuspid Valve
ADULT ECHOCARDIOGRAPHY Lesson Eight The Tricuspid Valve
Nat. Rev. Cardiol. doi: /nrcardio
ADULT ECHOCARDIOGRAPHY Lesson Seven The Mitral Valve
Diagnostic algorithm for pulmonary arterial hypertension (PAH).
Severe pulmonary hypertension (PH) in interstitial lung disease (ILD) stepwise composite echocardiographic score. Severe pulmonary hypertension (PH) in.
Pulmonary Hypertension Updates From 2018
Diagnostic algorithm. Diagnostic algorithm. PH: pulmonary hypertension; group: clinical group; TTE: transthoracic echocardiography; PFT: pulmonary function.
Selection of patients: 248 consecutive patients with newly diagnosed pre-capillary pulmonary hypertension were included in the study. Selection of patients:
Pulmonary Hypertension (PH)
Prevalence of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) according to defect. Prevalence of pulmonary arterial.
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Definition of pulmonary hypertension (PH) associated with left heart disease. mPAP: mean pulmonary arterial pressure; PAWP: pulmonary artery wedge pressure;
Presentation transcript:

Ipertensione polmonare Eco e diagnosi: vantaggi, limiti, errori evitabili Michele D’Alto mic.dalto@tin.it UOC Cardiologia II Università degli Studi, A.O. “V. Monaldi” - Napoli

Pulmonary hypertension: general definitions 2009

Pulmonary hypertension: haemodynamic definition 2009

WHO classification of pulmonary hypertension Venice 2003 revised Dana Point 2008 1. Pulmonary arterial hypertension Idiopathic PAH Heritable PAH (BMPR2, ALK1..) Drugs and toxins Associated with CTD, HIV, portal hypertension, congenital heart diseases, chronic hemolytic anemia (SSD) and shistosomiasis PPHN 1’ PVOD, PHCM 2. PH with left heart disease Systolic dysfunction Diastolic dysfunction Valvular 3. PH with lung diseases/hypoxemia COPD Interstitial lung diseases Sleep-disordered breathing Altitude exposure Alveolar hypoventilation Developmental abnormalities 4. CTEPH No more distinction proximal/distal 5. Miscellaneous Sarcoidosis, histiocytosis X, Gaucher,..

Normal estimated PAPs value at echo? 37 mmHg, but…

Echocardiography for PH diagnosis: pitfalls TVR Poor Doppler signal Uncertain TVR peak Theta angle RV systolic pressure estimation Simplified Bernoulli ΔP = 4 (V)2 TVR (simplified Bernoulli) + RAP estimation Arbitrary From ICV to… RAP

Echocardiography, age and body size Circulation 2001;104: 2797–802 J Am Coll Cardiol 2009;54:S55–66 3790 “normal” subjects (1358 M, 2432 F) from 1 to 89 years. PASP calculated by modified Bernoulli equation, with RAP assumed to be 10 mmHg. +10

Echocardiography, age and body size Circulation 2001;104: 2797–802

Echocardiography for PH in SSc Arthritis Rheum 2005;52(12):3792-3800 - 21 SSc expert centers - 599 SSc patients (-29 known PAH = 570) Reliability of prospective screening of SSc patients based on: TVR >2.5 m/s in symptomatic patients or TVR >3.0 m/s irrespective of symptoms. 33 patients 45% of cases of echocardiographic diagnoses of PH were falsely positive!

Echocardiography for PH in SSc Rheumatology 2004; 43:461-6 137 SSc pts studied false pos echo false neg cath

Estimated right atrial pressure Systolic PAP = RV-RA gradient + RAP ICV < 15mm collasso RAP 0-5 mmHg ICV 15-25mm rid. >50% RAP 5-10 mmHg ICV >25mm rid. <50% RAP 10-15 mmHg ICV >25mm+v.sovr. No rid. RAP 20 mmHg Mod from Otto CM, 2002

Estimated right atrial pressure Echocardiography for PH in HIV Am J Respir Crit Care Med 2009;179:615–621 65 HIV pts studied Estimated right atrial pressure IVC <20mm Collaps >50% IVC <20mm Collaps <50% IVC >20mm Collaps >50% IVC >20mm Collaps <50%

Echocardiography 65 HIV pts studied Good quality Doppler Am J Respir Crit Care Med 2009;179:615–621 65 HIV pts studied Good quality Doppler Poor quality Doppler 95% limits of agreement: +38.8 and -40.0 mmHg

additional echo variables 2009 PH possible: PASP 37-50 mmHg (TVR 2.9-3.4 m/s) additional echo variables PH likely: - PASP >50 (TVR > 3.4 m/s)

Echocardiography Direct PH signs Indirect PH signs PASP > 37 (50) mmHg Increased velocity PV reg (mPAP) Short acc. time in RVOT (mPAP) Right heart dilation Flat IV septum (LV EI <0.8) Increased RV wall thickness 2009

Indirect PH signs: PAPm 79 - 0.45 • (AcT) PAPm = 79 - 0.45 • 44.3 = 79 - 20 = 59 PAPm = 57 Mean PAP

Indirect PH signs: Right heart (and PA) dilation 57 mm Ao PA

Right atrium: and PAH cm2/m (area/altezza) Raymond, RJ, J Am Coll Cardiol 2002;39:1214–9

Right atrium size Normal value: <16 cm2 <9 cm2/m <40 ml <20 ml/m2 Raymond RJ, J Am Coll Cardiol 2002;39:1214–9 Wang Y, Chest 1984;86:595-601

Indirect PH signs: flat IV septum, hypertrophic RV wall Left ventricular (LV) eccentricity index (EI): D2/D1 in short axis view (normal value = 1) D2 D1 LV RV EI = 0.65

What determines PAPm? PVR = ΔP / Q PVR PVR = (PAPm – PWP) / Q ΔP Q PVR X Q = PAPm – PWP PVR X Q + PWP = PAPm High output LV dysfunction PAH

Three different conditions with high estimated PAPm (PVR X Q) + PWP = PAPm PAH High output LV dysfunction Argiento, Eur Respir J 2009

Assessment of LV filling pressures PCWP = 1.9 + (1.24 x E/Ea) NO PAH or very end-stage Normal LV filling pressure Precapillary PH first diagnosis 9/60 (15%) mistakes Nagueh et al. JACC 1997 & Circulation 2000

Midsystolic pulmonary artery notching = High PVR Rats were treated with monocrotaline for: 0 (A), 15 (B), 22 (C), 37 (D) days. 0 d monocrotaline 15 d monocrotaline Midsystolic pulmonary artery notching. Rats were treated with monocrotaline (MCT) for 0 (A), 15 (B), 22 (C), and 37 (D) days. Pulse-wave Doppler of pulmonary outflow was recorded in the parasternal view at the level of the aortic valve. Sample volume was placed (5 mm) proximal to the pulmonary valve leaflets and aligned to maximize laminar flow. Note the early notching at day 15 (B) and its subsequent progression. 22 d monocrotaline 37 d monocrotaline Jones J E, Am J Physiol Heart Circ Physiol 2002;283:364-71

Midsystolic pulmonary artery notching = High PVR Normal High PVR Very high PVR

Midsystolic pulmonary artery notching = High PVR Why? = reverse wave for high PVR

Pre-test probability: the Bayes’ theory The probability of an event A given an event B (e.g., the probability of CAD given a positive stress test) depends not only on the relationship between events A and B (i.e., the accuracy of stress test) but also on the marginal probability (or "simple probability") of occurrence of each event in a specific population. Rev. Thomas Bayes, 1763 Stress test for CAD detection: - CAD prevalence in group A = 50%; test + = 82% CAD - CAD prevalence in group B = 3%; test + = 13% CAD

Population at risk for PAH J Am Coll Cardiol 2008;51:1527–38 Relatives of IPAH patients Associated condition for PAH Connective tissue disease (CREST* 30%, SSc 10%) 10-15% Portal hypertension 1-6% HIV infection 0.5-1% Anorexigen drugs 0.006-0.01% Unoperated shunt 5-10% *CREST (calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia)

Pre-test probability of precapillary PH 2009

Pre-test probability of pre-capillary PH high RA > LA RV > LV D-shaped LV

Pre-test probability of pre-capillary PH low RA < LA RV < LV Normal shaped LV

PAH RV adaptation to pressure overload RV hypertrophy and progressive dilatation Tricuspid regurgitation and RA dilatation Paradoxical septal motion and altered LV filling Diastolic and systolic RV dysfunction Pericardial effusion in the more severe cases LV dysfunction Haddad et al. Circulation 2008

PAH PVH Pulmonary arterial or venous hypertension? RV dilation/hypertrophy LV dilation/hypertrophy RA enlargement LA enlargement E/A <1 (mild diastolic dysf) E/A >1 (pseudonorm/restr) PAH predisposing condition Left heart disease D-shape LV Normal LV shape PA notch No PA notch PAH PVH Group 1 Dana Point Group 2 Dana Point

Take-at-home message ECHO The gold standard for PAH diagnosis remains right heart catheterization! Echo plays a key-role in screening, differential diagnosis and follow-up. ECHO Echo does not provide “magic numbers”: multi-parametric evaluation! It is mandatory to evaluate the PAH “pre-test probability”. It is strongly encouraged a deep knowledge of PAH pathophysiology (echo as part of clinic evaluation!).